Australian biotech market watch 01/06/09
Monday, 01 June, 2009
All Ordinaries are up across the board by 1.5% as further signs of recovery were being warmly welcomed by stock markets around the world. In line with the rise, health indices are up 1.1% after high volumes of trading compared to a fairly deflated week last week. CSL Limited (ASX:CSL) up 45c to $29.65 on the back of the US Government placing a $230 million dollar order to produce Novel A (H1N1) influenza vaccine antigen. Other risers include Probiotec (ASX:PBP), up 11c to $1.86 and Sonic Healthcare (ASX:SHL), which lifted 2.5% to $12.12. Flurotechnics bucked the trend, plummeting a dramatic 64.3% to 25c and CathRx (ASX:CXD) dropped 4c to 51c after releasing its quarterly investor update.
Scientists complete final chromosome in synthetic yeast genome
The synthetic chromosome includes features that enable researchers to generate genetic diversity...
Self-destructing vaccine protects against TB in monkeys
A self-destructing vaccine administered intravenously provides additional safety and protection...
New drug to prevent migraine claimed to work straight away
People taking atogepant showed improvement on assessments of how much migraine impaired their...
